|
GB1419789A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
2-trifluoromethyl-4-quinolinols
|
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
|
US5482967A
(en)
|
1992-09-04 |
1996-01-09 |
Takeda Chemical Industries, Ltd. |
Condensed heterocyclic compounds, their production and use
|
|
EP1308461A3
(en)
|
1993-01-25 |
2004-02-11 |
Takeda Chemical Industries, Ltd. |
Antibodies to beta-amyloids or their derivatives and use thereof
|
|
ATE242243T1
(de)
|
1995-03-24 |
2003-06-15 |
Takeda Chemical Industries Ltd |
Zyklische verbindungen, ihre herstellung und ihre verwendung als tachykininrezeptorantagonisten
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
DK0994728T3
(da)
|
1997-04-09 |
2008-12-01 |
Intellect Neurosciences Inc |
Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
CA2322156A1
(en)
|
1998-03-03 |
1999-09-10 |
Ppg Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
CA2352612A1
(en)
|
1998-11-27 |
2000-06-08 |
Hideo Fukui |
Pharmaceuticals
|
|
HRP20020693B1
(hr)
|
2000-02-24 |
2012-01-31 |
Washington University |
HUMANIZIRANA PROTUTIJELA KOJA SADRŽE PEPTID Aß
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
CA2427661C
(en)
|
2000-11-03 |
2013-05-28 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
|
JP2005503789A
(ja)
|
2001-08-17 |
2005-02-10 |
イーライ・リリー・アンド・カンパニー |
抗Ａβ抗体
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
WO2004024078A2
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
|
US20040146512A1
(en)
|
2002-10-09 |
2004-07-29 |
Arnon Rosenthal |
Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
CA2501799C
(en)
|
2002-10-09 |
2008-06-17 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
|
AU2003301439A1
(en)
|
2002-10-16 |
2004-05-04 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
CA2528652A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
WO2005020991A1
(en)
|
2003-08-21 |
2005-03-10 |
Pfizer Products, Inc. |
Compounds for the treatment of neurodegenerative disorders
|
|
EP1666061A1
(en)
|
2003-09-09 |
2006-06-07 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
US20070155731A1
(en)
|
2004-01-28 |
2007-07-05 |
Gabor Butora |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
|
BRPI0507374A
(pt)
|
2004-02-02 |
2007-07-10 |
Pfizer Prod Inc |
moduladores do receptor de histamina-3
|
|
EP1725102A4
(en)
|
2004-03-09 |
2009-04-29 |
Merck & Co Inc |
HIV integrase
|
|
BRPI0509069B8
(pt)
|
2004-03-23 |
2021-05-25 |
Pfizer Prod Inc |
compostos de imidazol e composição farmacêutica que os compreende para o tratamento de distúrbios neurodegenerativos
|
|
PL1742642T3
(pl)
|
2004-04-14 |
2009-06-30 |
Gilead Sciences Inc |
Analogi fosfonianowe związków inhibitorów integrazy HIV
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
BRPI0513959A
(pt)
|
2004-07-30 |
2008-05-20 |
Rinat Neuroscience Corp |
anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
EP1881825B1
(en)
|
2005-05-10 |
2013-07-24 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
|
DE602006019231D1
(en)
|
2005-05-12 |
2011-02-10 |
Pfizer |
Wasserfreie kristalline formen von n-ä1,2-ethoxyethyl)-5-(n-ethyl-n-methylaminoü-7-(4-methylpyridin-2-yl-aminoü-1h-pyrazoloä4,3-düpyrimidin-3-carbonylümethansulfonsäureamid
|
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
|
WO2006126082A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
DE602006018301D1
(de)
|
2005-06-22 |
2010-12-30 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
WO2007052124A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
US20080275251A1
(en)
|
2005-11-18 |
2008-11-06 |
Glaxo Group Limited |
Novel Intermediates and Their Use
|
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
|
EP1953154A4
(en)
|
2005-11-24 |
2013-11-20 |
Eisai R&D Man Co Ltd |
CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
AU2007207481B2
(en)
*
|
2006-01-20 |
2012-08-23 |
Merck Sharp & Dohme Corp. |
Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
JP2009539762A
(ja)
|
2006-03-13 |
2009-11-19 |
ファイザー・プロダクツ・インク |
Ｈ３受容体のテトラリン拮抗薬
|
|
ATE513831T1
(de)
|
2006-04-21 |
2011-07-15 |
Pfizer Prod Inc |
Pyridinä3,4-büpyrazinone
|
|
CA2651153C
(en)
|
2006-05-15 |
2014-04-29 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
|
NZ572367A
(en)
|
2006-05-16 |
2011-09-30 |
Gilead Sciences Inc |
Fused cyclic compounds as integrase inhibitors
|
|
CA2651396A1
(en)
|
2006-05-19 |
2007-11-29 |
Eisai R&D Management Co., Ltd. |
Urea type cinnamide derivative
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
MX2009007782A
(es)
|
2007-01-22 |
2009-07-31 |
Pfizer Prod Inc |
Sal de tosilato de un compuesto terapeutico y composiciones farmaceuiticas de la misma.
|
|
CA2676920A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperidine derivatives
|
|
WO2008099210A2
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
PE20081791A1
(es)
|
2007-02-28 |
2009-02-07 |
Eisai Randd Man Co Ltd |
Dos derivados ciclicos de oxomorfolina
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
US8357682B2
(en)
|
2007-05-07 |
2013-01-22 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
MX2009012163A
(es)
|
2007-05-11 |
2009-12-01 |
Hoffmann La Roche |
Hetarilanilinas como moduladores para beta-amiloide.
|
|
CL2008001540A1
(es)
|
2007-05-29 |
2009-05-22 |
Sgx Pharmaceuticals Inc |
Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
|
|
AR066151A1
(es)
|
2007-06-01 |
2009-07-29 |
Schering Corp |
Moduladores de gama secretasa
|
|
US8426403B2
(en)
|
2007-06-01 |
2013-04-23 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
WO2008156580A1
(en)
|
2007-06-13 |
2008-12-24 |
Merck & Co., Inc. |
Triazole derivatives for treating alzheimer's disease and related conditions
|
|
CL2008001914A1
(es)
|
2007-06-29 |
2009-07-17 |
Schering Corp |
Compuestos heterociclicos de nitrogeno y oxigeno,moduladores de gama secretasa, composicion farmaceutica de dichos compuestos; kit farmaceutico y su uso para prevenir o tratar enfermedades asociadas al sistema nervioso central como alzheimer, sindrome de down, enfermedades neurodegenerativas, inhibir el deposito de proteina amiloide.
|
|
EP2185522A1
(en)
|
2007-08-06 |
2010-05-19 |
Schering Corporation |
Gamma secretase modulators
|
|
ES2529648T3
(es)
|
2007-08-31 |
2015-02-24 |
Eisai R&D Management Co., Ltd. |
Compuesto policíclico
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
EP2200990A1
(en)
|
2007-09-06 |
2010-06-30 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2010003397A
(es)
|
2007-09-28 |
2010-04-09 |
Schering Corp |
Moduladores de la gamma secretasa.
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2010005028A
(es)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
WO2009073779A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Schering Corporation |
Gamma secretase modulators
|
|
US8426595B2
(en)
|
2007-12-11 |
2013-04-23 |
Xianhai Huang |
Gamma secretase modulators
|
|
CN101970433A
(zh)
|
2007-12-11 |
2011-02-09 |
先灵公司 |
γ分泌酶调节剂
|
|
US20110166132A1
(en)
|
2007-12-13 |
2011-07-07 |
Amgen Inc. |
Gamma Secretase Modulators
|
|
ATE535515T1
(de)
|
2008-01-11 |
2011-12-15 |
Hoffmann La Roche |
Modulatoren für amyloid beta
|
|
CN101952275B
(zh)
|
2008-02-22 |
2014-06-18 |
弗·哈夫曼-拉罗切有限公司 |
β-淀粉样蛋白的调节剂
|
|
CA2716747A1
(en)
|
2008-02-29 |
2009-09-03 |
Schering Corporation |
Gamma secretase modulators for the treatment of alzheimer's disease
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
CA2722606A1
(en)
|
2008-05-05 |
2009-11-12 |
Amgen Inc. |
Urea compounds as gamma secretase modulators
|
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
|
US8685972B2
(en)
|
2008-08-13 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives for treatment of alzheimer's disease
|
|
CA2733606A1
(en)
|
2008-08-27 |
2010-03-04 |
Eisai R&D Management Co., Ltd. |
Process for preparing certain cinnamide compounds
|
|
BRPI0920651A2
(pt)
|
2008-10-09 |
2016-01-12 |
Hoffmann La Roche |
moduladores para amiloide beta
|
|
AU2009313524A1
(en)
|
2008-11-06 |
2010-05-14 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
JP2012507512A
(ja)
|
2008-11-06 |
2012-03-29 |
アストラゼネカ・アクチエボラーグ |
アミロイドβのモジュレーター
|
|
EP2356115A1
(en)
|
2008-11-06 |
2011-08-17 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2011004954A
(es)
|
2008-11-10 |
2011-05-30 |
Hoffmann La Roche |
Moduladores heterociclicos de gamma-secretasa.
|
|
WO2010071741A1
(en)
|
2008-12-16 |
2010-06-24 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of alzheimer's disease
|
|
WO2010077582A1
(en)
|
2008-12-16 |
2010-07-08 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of alzheimer's disease
|
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
|
PL2379525T3
(pl)
|
2008-12-19 |
2016-01-29 |
Centrexion Therapeutics Corp |
Cykliczne pirymidyno-4-karboksamidy jako antagoniści receptora CCR2 do leczenia stanów zapalnych, astmy oraz COPD
|
|
AU2009330233A1
(en)
|
2008-12-22 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
CA2747750A1
(en)
|
2008-12-22 |
2010-07-01 |
Theodros Asberom |
Gamma secretase modulators
|
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
|
EP2393804B1
(en)
|
2009-02-06 |
2014-04-16 |
Janssen Pharmaceuticals, Inc. |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
|
TWI461425B
(zh)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
|
CN102333778B
(zh)
|
2009-02-26 |
2015-05-13 |
卫材R&D管理有限公司 |
四氢三唑并吡啶衍生物的盐及其晶体
|
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
|
US20120053165A1
(en)
|
2009-03-03 |
2012-03-01 |
Pfizer Inc. |
Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
|
|
AP3534A
(en)
|
2009-08-07 |
2016-01-13 |
Dow Agrosciences Llc |
Pesticidal compositions
|
|
CA2776480A1
(en)
*
|
2009-10-20 |
2011-04-28 |
Pfizer Inc. |
Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
|
|
CA2785499C
(en)
*
|
2009-12-22 |
2017-05-02 |
Vertex Pharmaceuticals Incorporated |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
|
EP2691393B1
(en)
|
2011-03-31 |
2016-09-14 |
Pfizer Inc |
Novel bicyclic pyridinones
|
|
JP6106745B2
(ja)
|
2012-05-16 |
2017-04-05 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
（特に）アルツハイマー病の治療に有用な置換３，４−ジヒドロ−２Ｈ−ピリド［１，２−ａ］ピラジン−１，６−ジオン誘導体
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
CA2889249C
(en)
|
2012-12-20 |
2021-02-16 |
Francois Paul Bischoff |
Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
|
|
CA2891755C
(en)
|
2013-01-17 |
2021-10-26 |
Janssen Pharmaceutica Nv |
Substituted pyrido-piperazinone derivatives as gamma secretase modulators
|
|
EP3052495B1
(en)
|
2013-10-04 |
2019-06-26 |
Pfizer Inc |
Novel bicyclic pyridinones as gamma-secretase modulators
|
|
CN115068134B
(zh)
|
2014-03-21 |
2024-11-19 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
DK3126361T3
(da)
|
2014-04-01 |
2020-01-02 |
Pfizer |
Chromen og 1,1a,2,7b-tetrahydrocyclopropa[c]chromen- pyridopyrazindioner som gamma-sekretase-modulatorer
|